<DOC>
	<DOCNO>NCT00612417</DOCNO>
	<brief_summary>Single administration recombinant FVIII/placebo healthy male subject treat single dose anti-factor VIII antibody , TB-402</brief_summary>
	<brief_title>Effect Recombinant FVIII Healthy Male Subjects Treated With TB-402</brief_title>
	<detailed_description />
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Inclusion Criteria include : Males 18 45 year age Healthy accord medical history , physical exam , ECG , blood pressure heart rate , laboratory profile blood urine Exclusion Criteria include : Self family history cardiovascular pulmonary disorder , coagulation bleed disorder reasonable suspicion vascular malformation e.g . cerebral haemorrhage , aneurysm premature stroke History important bleeding episode Previous allergic reaction immunoglobulin Present previous history severe allergy , example asthma anaphylactic reaction FVIII : C &lt; 50 % &gt; 150 % screen Clinically significant range value coagulation test screening Received prescribed medication , counter medication herbal medicine within 14 day receipt TB402</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Interaction recombinant FVIII</keyword>
</DOC>